Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02168088 · ClinicalTrials.gov registry record
Molecular Autopsy Study
A clinical trial of Sudden Unexplained Death, sponsored by Scripps Translational Science Institute.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT02168088: Recruiting study of Sudden Unexplained Death, sponsored by Scripps Translational Science Institute.
NCT02168088 is a study of Sudden Unexplained Death that is actively recruiting participants, run by Scripps Translational Science Institute. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02168088, a study of Sudden Unexplained Death, is actively recruiting participants, sponsored by Scripps Translational Science Institute.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to incorporate genetic testing into the postmortem examination of cases of sudden unexplained death.
Primary Outcome
The primary endpoint for this study is the discovery of genomic information that may help identify a potential cause of death in the index case. This information may inform living, biologically related family members of their potential risk and need for further genomic analysis.
Conditions Studied
Study Locations (1)
California
- Scripps Translational Science Institute - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-06 |
| Est. Completion | 2030-06 |
What NCT02168088 shows while recruiting
NCT02168088 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Sudden Unexplained Death appearing as the primary indexed condition, and to 0 interventions.
NCT02168088 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02168088 about?
NCT02168088 is a clinical study titled "Molecular Autopsy Study". This study seeks to incorporate genetic testing into the postmortem examination of cases of sudden unexplained death.
What is the current status of trial NCT02168088?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2014-06. Estimated completion is 2030-06.
What conditions does trial NCT02168088 study?
This clinical trial studies the following conditions: Sudden Unexplained Death.
Who is sponsoring clinical trial NCT02168088?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02168088 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia